Table 2.

Comparison of the survival rates of patients with hepatocellular carcinoma in this study versus the survival rates of patients in the original SNACOR study

SNACOR, 3 subgroups	Low risk, 0–2 points	Intermediate risk, 3–6 points	High risk, 7–10 points	P-value
This study: median OS (95% CI), m	31.5 (23.1–46.0)	19.9 (17.1–26.2)	9.2 (6.2–21.7)	< 0.001
Original SNACOR study: median OS (95% CI), m	49.8 (34.3–65.3)	30.7 (25.8–35.6)	12.4 (5.9–18.9)	< 0.001